Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
Click here to view the accompanying paper in this issue.
Main Authors: | Elia, A. E., Lalli, S., Monsurrò, M. R., Sagnelli, A., Taiello, A. C., Reggiori, B., La Bella, V., Tedeschi, G., Albanese, A. |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024041/ |
Similar Items
-
Amyotrophic Lateral Sclerosis and Multiple Sclerosis Overlap: A Case Report
by: Trojsi, Francesca, et al.
Published: (2012) -
Exposure to Environmental Toxicants and Pathogenesis of Amyotrophic Lateral Sclerosis: State of the Art and Research Perspectives
by: Trojsi, Francesca, et al.
Published: (2013) -
Widespread Structural and Functional Connectivity Changes in Amyotrophic Lateral Sclerosis: Insights from Advanced Neuroimaging Research
by: Trojsi, Francesca, et al.
Published: (2012) -
Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis
by: Trojsi, Francesca, et al.
Published: (2015) -
Amyotrophic lateral sclerosis and neuroregeneration
Published: (2012)